247 related articles for article (PubMed ID: 28780618)
21. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
Wang C; Tian Y; Ye Z; Kijlstra A; Zhou Y; Yang P
Arthritis Res Ther; 2014 May; 16(3):R117. PubMed ID: 24887071
[TBL] [Abstract][Full Text] [Related]
22. CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis.
Ahn JK; Chung H; Lee DS; Yu YS; Yu HG
J Immunol; 2005 Nov; 175(9):6133-42. PubMed ID: 16237110
[TBL] [Abstract][Full Text] [Related]
23. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of the profile of CD4+ cells in Behçet's disease].
Sugi N; Nakazawa M; Nakamura S; Minami M; Ohno S
Nippon Ganka Gakkai Zasshi; 1997 Apr; 101(4):335-40. PubMed ID: 9136573
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil and lymphocyte responses to oral Streptococcus in Adamantiades-Behçet's disease.
Kurauchi T; Yokota K; Matsuo T; Fujinami Y; Isogai E; Isogai H; Ohtsuki H; Oguma K
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):125-31. PubMed ID: 15681141
[TBL] [Abstract][Full Text] [Related]
26. IL-17A and IFN-γ are Up-regulated in CD4 and γδ T Cells in Active Behcet's Disease Patients.
Abbasova V; Gül A; Saruhan-Direskeneli G
Immunol Lett; 2022 Feb; 242():37-45. PubMed ID: 34838533
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of IL-22 is associated with disease activity in Behcet's disease.
Cai T; Wang Q; Zhou Q; Wang C; Hou S; Qi J; Kijlstra A; Yang P
PLoS One; 2013; 8(3):e59009. PubMed ID: 23527071
[TBL] [Abstract][Full Text] [Related]
28. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.
Amberger M; Groll S; Günaydin I; Deuter C; Vonthein R; Kötter I
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552
[TBL] [Abstract][Full Text] [Related]
29. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
Shen H; Xia LP; Lu J
Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
[TBL] [Abstract][Full Text] [Related]
30. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity.
Sim JH; Park MJ; Park S; Lee ES
Br J Dermatol; 2011 Jun; 164(6):1285-91. PubMed ID: 21574973
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.
Li F; Yang P; Liu X; Wang C; Hou S; Kijlstra A
Arch Ophthalmol; 2010 Nov; 128(11):1449-54. PubMed ID: 21060047
[TBL] [Abstract][Full Text] [Related]
32. Increased Notch pathway activation in Behçet's disease.
Qi J; Yang Y; Hou S; Qiao Y; Wang Q; Yu H; Zhang Q; Cai T; Kijlstra A; Yang P
Rheumatology (Oxford); 2014 May; 53(5):810-20. PubMed ID: 24446471
[TBL] [Abstract][Full Text] [Related]
33. IL-1β triggered by peptidoglycan and lipopolysaccharide through TLR2/4 and ROS-NLRP3 inflammasome-dependent pathways is involved in ocular Behçet's disease.
Liang L; Tan X; Zhou Q; Zhu Y; Tian Y; Yu H; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):402-14. PubMed ID: 23211828
[TBL] [Abstract][Full Text] [Related]
34. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease.
Yilmaz S; Cinar M; Pekel A; Simsek I; Musabak U; Erdem H; Pay S
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):84-7. PubMed ID: 24064021
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 (IL-6) in patients with Behçet's disease.
Yamakawa Y; Sugita Y; Nagatani T; Takahashi S; Yamakawa T; Tanaka S; Nakamura S; Ohno S; Sekihara H; Okuda K; Nakajima H
J Dermatol Sci; 1996 Mar; 11(3):189-95. PubMed ID: 8785169
[TBL] [Abstract][Full Text] [Related]
36. The exaggerated inflammatory response in Behçet's syndrome: identification of dysfunctional post-transcriptional regulation of the IFN-γ/CXCL10 IP-10 pathway.
Ambrose N; Khan E; Ravindran R; Lightstone L; Abraham S; Botto M; Johns M; Haskard DO
Clin Exp Immunol; 2015 Sep; 181(3):427-33. PubMed ID: 25982097
[TBL] [Abstract][Full Text] [Related]
37. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
[TBL] [Abstract][Full Text] [Related]
38. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease.
Tian Y; Wang C; Ye Z; Xiao X; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6434-41. PubMed ID: 22918640
[TBL] [Abstract][Full Text] [Related]
39. Serum Cytokine Levels in Behçet's Disease.
Akkurt ZM; Bozkurt M; Uçmak D; Yüksel H; Uçak H; Sula B; Gürsel Özkurt Z; Yildiz M; Akdeniz D; Arica M
J Clin Lab Anal; 2015 Jul; 29(4):317-20. PubMed ID: 25130392
[TBL] [Abstract][Full Text] [Related]
40. IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behçet's disease.
Hamzaoui A; Ghraïri H; Ammar J; Zekri S; Guemira F; Hamzaoui K
Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S8-14. PubMed ID: 14727452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
